PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
18-Sep-2020 SciBite launches state-of-the-art AI platform for Life Sciences organisations SciBite
18-Sep-2020 Positive clinical results for TG4001 and TG6002 and financial visibility secured until 2022 Transgene
18-Sep-2020 Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020 Merck
18-Sep-2020 OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020 Oxford Biomedica plc
18-Sep-2020 NOVO VENTURES CO-LEADS US$83M SERIES C FINANCING IN LAVA THERAPEUTICS About Novo Holdings A/S
18-Sep-2020 PARTNERSHIP ACCELERATES DRUG DEVELOPMENT Quay Pharma
18-Sep-2020 RevoluGen Announces Positive Validation Data for its DNA Extraction Kit From Quadram Institute RevoluGen
18-Sep-2020 Liverpool John Moores University gives students a Better insight into e-prescribing Liverpool John Moores University
18-Sep-2020 Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors Surufatinib
18-Sep-2020 Canine Stem Cell Therapy Industry Revenue Analysis with Impact of COVID19 InForGrowth
18-Sep-2020 Oxurion NV Business Update and First Half 2020 Financial Results to be announced on 17 September Oxurion
18-Sep-2020 In times of crisis, shortages can be avoided with supply chain resilience AESGP reacts to European Parliament Report on shortages of medicines The Association of the European Self-Care Industry
18-Sep-2020 US Congressman commends the contribution of SP Industries in the fight against COVID-19 SP Industries, Inc.
18-Sep-2020 Vifor Pharma Group announces successful sale of OM Pharma Vifor Pharma Group
18-Sep-2020 Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020 Helsinn
18-Sep-2020 Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO Regeneron Pharmaceuticals, Inc.
18-Sep-2020 UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis UCB
18-Sep-2020 Lynparza improved median time patients lived without disease progression to over four and half years in BRCA-mutated advanced ovarian cancer vs. just over one year with placebo AstraZeneca
17-Sep-2020 PharmiWeb.Jobs Welcomes Northreach Northreach
17-Sep-2020 2020 PM Society Digital Awards - Winners Announced PM Society